Research

Madison Memory Study

In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function over 90 days in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening.

Madison Memory Study

study-page

Safety Study I

Apoaequorin, the main ingredient in Prevagen, showed no adverse effects when taken orally using a toxicity study for evaluating dietary supplements.

study-page

Safety Study II

Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested.

study-page2

study-page

Safety Study III

In a third study conducted on the safety of apoaequorin, apoaequorin showed no adverse effects when taken orally.

study-page

 

 


Click to
Scroll
Do NOT follow this link or you will be banned from the site!
We’ve updated our privacy policy.
Please read the updated Privacy Policy so you can see the changes that may be important to you before you continue using our services.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.
×
×
WordPress Popup Plugin